Missouri
Prescription drug spending and prescribing in Missouri, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $6.0B for prescriptions written in Missouri, the 16th most of 52 states and territories, and 3.9% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $6.0B
- Medicaid drugs, 2025: $2.0B
- Opioid share of claims: 3.9%
- Life-science raises, 2 years: $238M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Missouri | United States | Difference |
|---|---|---|---|
| Opioids | 3.9% | 3.5% | +11% |
| Antibiotics | 4.0% | 4.4% | -9% |
| Antipsychotics | 2.0% | 1.7% | +17% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Missouri's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Paliperidone | 2.1× | 19,531 |
| Pen Needle,dual Safety,diabetc | 2.1× | 18,332 |
| Medroxyprogesterone Acetate | 2.0× | 18,416 |
| Chlorpromazine Hcl | 1.9× | 11,050 |
| Brexpiprazole | 1.9× | 26,101 |
| Prazosin Hcl | 1.8× | 53,885 |
| Colestipol Hcl | 1.8× | 21,906 |
| Paliperidone Palmitate | 1.6× | 26,508 |
| Ropinirole Hcl | 1.6× | 132,601 |
| Vortioxetine Hydrobromide | 1.6× | 23,067 |
Biggest Medicaid Drugs
What Missouri's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
17 Form D raises by companies based in Missouri in the last two years; the 10 largest. See all raises- Wugen, Inc.$123M · Other health care · Sep 8, 2025
- Particle Dynamics Holdings, Inc.$31M · Other health care · Oct 2, 2025
- MediBeacon Inc.$16M · Other health care · Jan 31, 2025
- Immunophotonics, Inc.$10M · Pharma · Sep 4, 2026
- C2N JMK, Inc.$10M · Biotech · Aug 6, 2025
- C2N Diagnostics, LLC$10M · Biotech · May 30, 2025
- Bond Biosciences, Inc.$8M · Other health care · Apr 8, 2026
- Charlestowne Senior Village LLC$6M · Other health care · Sep 11, 2026
- Panome Bio Inc.$6M · Biotech · Nov 21, 2024
- Trially Inc.$5M · Other health care · Aug 21, 2025
State Attorney General Health-Care Cases
Antitrust cases Missouri joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)2019 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Florida et al. v. Abbott Laboratories et al., No. 1:08-cv-00155-SLR (D.Del. 2007)2007 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- In the Matter of Medical Transportation Management, Inc.,–Letter Agreement from Missouri AG, Sept. 21, 2005)2005 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG